Alcohol
Volume 26, Issue 1 , Pages 31-34 , January 2002

Do Spanish patients drink alcohol while undergoing treatment with benzodiazepines?

Received 27 April 2001 ,Revised 1 August 2001 ,Accepted 6 September 2001.

References 

  1. Barbone F, McMahon AD, Davey PG, Morris AD, Reid IC, McDevitt DG, et al. Association of road-traffic accidents with benzodiazepine use. Lancet. 1998;352:1331–1336
  2. Del Rı́o C, Prada C, Alvarez FJ. Beverage effects on patterns of alcohol consumption. Alcohol Clin Exp Res. 1995;19:1583–1586
  3. Del Rı́o MC, Alvarez FJ. How benzodiazepines are prescribed in a primary health care setting in Spain. Therapie. 1996;51:185–189
  4. Del Rı́o MC, Prada C, Alvarez FJ. The use of medication and alcohol among the Spanish population. Br J Clin Pharmacol. 1996;41:253–255
  5. Glass RM. Benzodiazepine prescription regulation: autonomy and outcome (Editorial). JAMA. 1991;266:2431–2433
  6. Gutierrez-Lobos K, Frohlich S, Quiner S, Haring C, Barnas C. Prescription patterns and quality of information provided for consumers of benzodiazepines. Acta Med Austriaca. 2001;28:56–59
  7. Harris RA, Mihic SJ, Valenzuela CF. Alcohol and benzodiazepines: recent mechanistic studies. Drug Alcohol Depend. 1998;51:155–164
  8. Joukamaa M, Sohlman B, Lehtinen V. The prescription of psychotropic drugs in primary health care. Acta Psychiatr Scand. 1995;92:359–364
  9. Lekka NP, Paschalis C, Beratis S. Nicotine, caffeine and alcohol use in high- and low-dose benzodiazepine users. Drug Alcohol Depend. 1997;45:207–212
  10. Magrini N, Vaccheri A, Parma E, D’Alessandro R, Bottoni A, Occhionero M, et al. Use of benzodiazepines in the Italian general population: prevalence, pattern of use and risk factors for use. Eur J Clin Pharmacol. 1996;50:19–25
  11. Ministerio de Sanidad y Consumo . Encuesta Nacional de Salud 1997. Madrid: Ministerio de Sanidad y Consumo; 2000;
  12. Neutel I. Benzodiazepine-related traffic accidents in young and elderly drivers. Hum Psychopharmacol Clin Exp. 1998;13:115–123
  13. Ohayon MM, Caulet M, Priest RG, Guilleminault C. Psychotropic medication consumption patterns in the UK general population. J Clin Epidemiol. 1998;51:273–283
  14. Posternak MA, Mueller TI. Assessing the risks and benefits of benzodiazepines for anxiety disorders in patients with a history of substance abuse or dependence. Am J Addict. 2001;10:48–68
  15. Rayón P, Serrano-Castro M, Del Barrio H, Alvarez C, Montero D, Madurga M, et al. Hypnotic drug use in Spain: a cross-sectional study based on a network of community pharmacies. Spanish Group for the Study of Hypnotic Drug utilization. Ann Pharmacother. 1996;30:1092–1100
  16. Rodrı́guez-Martos A, Gual A, Llopis JJ. La “unidad de bebida estandar” como registro simplificado del consumo de bebidas alcohólicas y su determinación en España. Med Clin. 1999;112:446–450
  17. Simon GE, VonKorff M, Barlow W, Pabiniak C, Wagner E. Predictors of chronic benzodiazepine use in a health maintenance organization sample. J Clin Epidemiol. 1996;49:1067–1073
  18. Tanaka E, Misawa S. Pharmacokinetic interactions between acute alcohol ingestion and single doses of benzodiazepines, and tricyclic and tetracyclic antidepressants: an update. J Clin Pharm Ther. 1998;23:331–336
  19. Tiller JWG. Reducing the use of benzodiazepines in general practice. Br Med J. 1994;309:3–4
  20. van der Waals FW, Mohrs J, Foets M. Sex differences among recipients of benzodiazepines in Dutch general practice. BMJ. 1993;307:363–366
  21. van Hulten R, Leufkens HG, Bakker A. Usage patterns of benzodiazepines in a Dutch community: a 10-year follow-up. Pharm World Sci. 1998;20:78–82
  22. Weintraub M, Singh S, Byme L, Maharaj K, Guttmacher L. Consequences of the 1989 New York State triplicate benzodiazepine prescription regulations. JAMA. 1991;266:2392–2397

PII: S0741-8329(01)00195-1

Alcohol
Volume 26, Issue 1 , Pages 31-34 , January 2002

Article Tools

* Image Usage & Resolution